Meeting
2020 Gastrointestinal Cancers Symposium
Con
Presenter
Barbara Burtness, MD
Yale University School of Medicine and Yale Cancer Center
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
General Session
Session Title
Debate: FLOT or Not—Revisiting the Current and Future Role of Radiotherapy in Gastroesophageal Junction Cancers
Track
Cancers of the Esophagus and Stomach
Similar Videos & Slides
Videos & Slides
2011 ASCO Annual Meeting
CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma.
Speaker: Vincent Verschaeve, MD
Speaker: Arlene O. Siefker-Radtke, MD
Videos & Slides
2011 ASCO Annual Meeting
Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM).
Speaker: Antonio Marcilio Padula Omuro, MD
Videos & Slides
2022 ASCO Annual Meeting
Baseline tumor genomic and gut microbiota association with clinical outcomes in newly diagnosed glioblastoma (GBM) treated with atezolizumab in combination with temozolomide (TMZ) and radiation.
Speaker: Shiao-Pei S. Weathers, MD